Suppr超能文献

重度高血压患者通过递增输注拉贝洛尔降低血压

Blood pressure reduction by incremental infusion of labetalol in patients with severe hypertension.

作者信息

Cummings A M, Brown J J, Fraser R, Lever A F, Morton J J, Richards D A, Robertson J I

出版信息

Br J Clin Pharmacol. 1979 Oct;8(4):359-64. doi: 10.1111/j.1365-2125.1979.tb04719.x.

Abstract
  1. Labetalol was given by incremental intravenous infusion to nineteen severely hypertensive patients, of whom nine were refractory to previous oral antihypertensive therapy. 2. Smooth reduction of arterial pressure was achieved in twelve subjects; one remained resistant to labetalol up to 160 mg/h; a sudden fall in pressure occurred in the remaining six. No serious complications were encountered. Blood pressure control was accompanied by slight byt significant reduction in heart rate and in plasma angiotensin II and aldosterone concentrations. 3. The administration of labetalol in this way appears to be a useful technique in patients requiring rapid reduction of arterial pressure, although close and continuous supervision is necessary.
摘要
  1. 对19例重度高血压患者进行拉贝洛尔递增静脉输注给药,其中9例对先前的口服抗高血压治疗无效。2. 12例患者动脉压平稳下降;1例对拉贝洛尔高达160mg/h仍有抵抗;其余6例血压突然下降。未出现严重并发症。血压得到控制的同时,心率、血浆血管紧张素II和醛固酮浓度略有但显著降低。3. 尽管需要密切持续监测,但以这种方式给予拉贝洛尔似乎是一种对需要快速降低动脉压的患者有用的技术。

相似文献

1
Blood pressure reduction by incremental infusion of labetalol in patients with severe hypertension.
Br J Clin Pharmacol. 1979 Oct;8(4):359-64. doi: 10.1111/j.1365-2125.1979.tb04719.x.
4
Labetalol infusion in hypertensive emergencies.
Clin Pharmacol Ther. 1985 Jun;37(6):615-8. doi: 10.1038/clpt.1985.98.
5
Intravenous labetalol in the treatment of severe hypertension.
Br J Clin Pharmacol. 1982 Jun;13(1 Suppl):93S-96S. doi: 10.1111/j.1365-2125.1982.tb01895.x.
6
Emergency treatment of severe hypertension with intravenous labetalol.
Med J Aust. 1978 Oct 21;2(9):410-1. doi: 10.5694/j.1326-5377.1978.tb76817.x.
7
Labetalol and 24-hour monitoring of arterial blood pressure in hypertensive patients.
J Cardiovasc Pharmacol. 1981;3 Suppl 1:S42-52. doi: 10.1097/00005344-198100031-00005.
8
Labetalol (AH5158), a competitive alpha- and beta-receptor blocking drug, in the management of hypertension.
Aust N Z J Med. 1976 Aug;6(3 Suppl):83-8. doi: 10.1111/j.1445-5994.1976.tb03341.x.

引用本文的文献

1
Intravenous labetalol in the treatment of severe hypertension.
Br J Clin Pharmacol. 1982 Jun;13(1 Suppl):93S-96S. doi: 10.1111/j.1365-2125.1982.tb01895.x.
2
Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Drugs. 1984;28 Suppl 2:51-68. doi: 10.2165/00003495-198400282-00005.
3
The management of hypertension.
Br J Clin Pharmacol. 1986;21 Suppl 2(Suppl 2):129S-142S. doi: 10.1111/j.1365-2125.1986.tb02862.x.

本文引用的文献

1
Hemodynamic effects of guanethidine in man.
Circ Res. 1963 Mar;12:298-307. doi: 10.1161/01.res.12.3.298.
2
Clinical and chemical studies with alpha-methyl-dopa in patients with hypertension.
Circulation. 1962 Feb;25:281-91. doi: 10.1161/01.cir.25.2.281.
3
Effect of diazoxide on plasma renin activity in hypertensive patients.
Ann Intern Med. 1967 Oct;67(4):791-9. doi: 10.7326/0003-4819-67-4-791.
7
9
Metabolism of labetalol by animals and man.
Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):695-710.
10
Letter: Diazoxide and myocardial ischemia.
Ann Intern Med. 1976 Sep;85(3):395. doi: 10.7326/0003-4819-85-3-395_1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验